Miller Joseph M
SEC CIK 1746372 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | CFO | 576.4K | — | $1.37M | 14 | 2022-03-02 | 2026-03-02 |
Most active insiders at AUPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | Dir | $25.14M | — |
| 2 | Robertson Stephen P. | EVP, GC | — | $546.4K |
| 3 | Cole Ryan | COO | — | — |
| 4 | Keenan Greg | SVP, Chief Medical Off | — | — |
| 5 | Hearne Michael S | CFO | — | — |
| 6 | Miller Joseph M | CFO | — | — |
| 7 | Donley Matthew Maxwell | COO | — | — |
| 8 | Bailey Jeffrey Allen | Dir | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Greenleaf Peter | CEO, Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | F - Tax | $14.21 | -37.5K | 576.4K | -6% | -$533.0K |
| D | 2026-03-03 | 2026-02-27 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | A - Grant | $0.00 | +57.2K | 613.9K | +10% | $0 |
| 2026-02-23 | 2026-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | F - Tax | $14.40 | -32.4K | 556.7K | -6% | -$466.9K | |
| 2026-01-05 | 2026-01-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | A - Grant | $0.00 | +49.0K | 626.4K | +8% | $0 | |
| 2026-01-05 | 2026-01-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | F - Tax | $15.95 | -40.2K | 589.1K | -6% | -$640.6K | |
| DM | 2025-03-04 | 2025-03-03+ | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | S - Sale | $7.96 | -118.0K | 633.5K | -16% | -$939.6K |
| DM | 2025-03-04 | 2025-02-28+ | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | A - Grant | $0.00 | +196.2K | 695.4K | +39% | $0 |
| 2024-03-07 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | S - Sale | $5.60 | -34.8K | 495.9K | -7% | -$194.9K | |
| A | 2024-02-22 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | S - Sale | $8.78 | -11.4K | 331.1K | -3% | -$100.1K |
| 2024-02-22 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | A - Grant | $0.00 | +196.2K | 530.7K | +59% | $0 | |
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | A - Grant | — | +229.4K | 342.5K | +203% | — | |
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | S - Sale | $8.94 | -11.3K | 331.2K | -3% | -$101.0K | |
| D | 2022-03-04 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | S - Sale | $12.01 | -3,060 | 6,610 | -32% | -$36.8K |
| D | 2022-03-04 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | CFO | A - Grant | $0.00 | +8,500 | 9,670 | +726% | $0 |
Purchase Sale Sale after option exercise All abbreviations